Stem Cell Market Research
47 views | +0 today
Follow
Stem Cell Market Research
This topic contains all Stem cell market research and cord blood banking related research reports.
Your new post is loading...
Your new post is loading...
Scooped by Mark Stiffler - Seven Seas Research
Scoop.it!

Strategic Development of Neural Stem & Progenitor Cell Products (Jan 2012)

Strategic Development of Neural Stem & Progenitor Cell Products (Jan 2012) | Stem Cell Market Research | Scoop.it
Strategic Development of Neural Stem & Progenitor Cell Products (Jan 2012)

 

Call us now and claim this study at a DISCOUNTED PRICE:

Ph: 754-264-0777

Email: info@sevenseasresearch.com

Mark Stiffler - Seven Seas Research's insight:

 

Strategic Development of Neural Stem & Progenitor Cell Products (Jan 2012)

 

Neurogenesis is the process by which neurons are created. This process is most active during pre-natal development when neurogenesis is responsible for populating the growing brain. Neural stem cells (NSCs) are the self-renewing, multipotent cells that differentiate into the main phenotypes of the nervous system. These cell types include neurons, astrocytes, and oligodendrocytes. Neural progenitor cells (NPCs) are the progeny of stem cell division that normally undergo a limited number of replication cycles in vivo.


The terms neuronal and neural also need to be defined. Technically speaking, “neuronal” means “pertaining to neurons,” and “neural” means “pertaining to nerves, which are the cordlike bundles of fibers made up of neurons.” Since both terms ultimately are descriptive of neurons, the scientific community uses the terms "neuronal" and "neural" interchangeably. The complexity of this issue is explored from a marketing perspective within this report.


Key Findings: Claim this 160-page industry report to understand your key strengths relative to the competition, intelligently position your products to fill gaps in the market place, and take advantage of crucial NSC trends. Key report findings include: - Charts, Timelines, and Financials for the NSC Product Market - Trends for NSC Grants, Scientific Publications, and Patents - 5-Year Market Size Projections (2013-2017) - Key Advances in NSC Research Applications - Research Priorities by Market Segment - Competitive Analysis of NSC Product & Technology Companies - Overview of Specialty Pharmaceutical Companies Developing NSC Therapies - And Much More.


For a full table of contents and to access free product samples from the “Strategic Development of Neural Stem & Progenitor Cell Products (Jan 2012)”, please visit:http://sevenseasresearch.com/index.php?route=product/product&product_id=60&search=Strategic

 

 

Call us now and claim this study at a DISCOUNTED PRICE:

 

Ph: 754-264-0777

Email: info@sevenseasresearch.com

www.sevenseasresearch.com


more...
No comment yet.
Scooped by Mark Stiffler - Seven Seas Research
Scoop.it!

Opportunities in Human Embryonic Stem Cell (hESC) Products - Trends and Forecasts to 2017

Opportunities in Human Embryonic Stem Cell (hESC) Products - Trends and Forecasts to 2017 | Stem Cell Market Research | Scoop.it
When the maturation of embryo stops, the cells multiply to make more undifferentiated cells that resemble the cells of the inner cell mass hence called Embryonic Stem Cells.

 

Call us now and claim this study at a DISCOUNTED PRICE:

Ph: 754-264-0777

Email: info@sevenseasresearch.com

Mark Stiffler - Seven Seas Research's insight:

 

Opportunities in Human Embryonic Stem Cell (hESC) Products - Trends and Forecasts to 2017

 

Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Categorized by stage of life, several broad categories of stem cells exist, including:

 

Embryonic stem cells, derived from blastocystsPost-natal stem cells, derived from newborn tissuesAdult stem cells, found in adult tissues – including hematopoietic stem cells, mesenchymal stem cells, neural stem cells, and moreInduced pluripotent stem cells, reprogrammed from adult cellsCancer stem cells, which give rise to clonal populations of cells that form tumors or disperse in the body 

Embryonic stem cells are stem cells derived from the inner cell mass of a blastocyst, which is a stage reached four to five days post-fertilization. They are the most pluripotent of all stem cell types and can develop into over 200 different cell types of the human body.


Human embryonic stem cells (hESCs) were first derived from mouse embryos in 1981 by Martin Evans and Matthew Kaufman, and independently by Gail R. Martin. In 1995, the first successful culturing of embryonic stem cells from non-human primates occurred at the University of Wisconsin-Madison. Another breakthrough followed at the University of Wisconsin-Madison in November 1998 when a group led by Dr. James Thomson developed a technique to isolate and grow hESCs derived from human blastocysts.


For a full table of contents and to access free product samples from the “Opportunities in Human Embryonic Stem Cell (hESC) Products - Trends and Forecasts to 2017”, please visit: http://sevenseasresearch.com/index.php?route=product/product&product_id=53&search=Human

 

 

Call us now and claim this study at a DISCOUNTED PRICE:

 

Ph: 754-264-0777

Email: info@sevenseasresearch.com

www.sevenseasresearch.com

 


more...
No comment yet.
Scooped by Mark Stiffler - Seven Seas Research
Scoop.it!

Complete 2013-14 U.S. Cord Blood Banking Industry Report (September 2013)

Complete 2013-14 U.S. Cord Blood Banking Industry Report (September 2013) | Stem Cell Market Research | Scoop.it
Stem cells derived from umbilical blood have been used in more than 30,000 transplants worldwide to treat a wide range of blood diseases

 

Call us now and claim this study at a DISCOUNTED PRICE:

Ph: 754-264-0777

Email: info@sevenseasresearch.com

Mark Stiffler - Seven Seas Research's insight:

 

Complete 2013-14 U.S. Cord Blood Banking Industry Report (September 2013)

 

Just launched, the “Complete 2013-14 U.S. Cord Blood Banking Industry Report” reveals strategies for dominating the U.S. cord blood banking industry, including methods for out-competing the competition, increasing profits, and better serving the needs of prospective clients. It explores the industry’s potential for the next several years and how company management can capitalize on emerging opportunities

 

A distinctive feature of this report is a survey of U.S parents who reveal perspectives about cord blood banking services, including their core needs, expectations, and factors influencing buying decisions. In reference to the “Expectant Parent Survey” contained within the report, Breastgoff said, “The report provides insights into the minds of hundreds of expectant parents, revealing how they evaluate cord blood banking services and why they would choose your services over the competition.”

As of 2013, the cord blood banking industry is one of the fastest growing industries in the world.  In 2005, there were only 23 active cord blood banks worldwide; today there are 485. This represents a 21-fold increase (2,100%) in cord blood industry growth, in less than a ten year period.

 

Within the United States, cord blood banks now exist in nearly every state. Furthermore, the U.S. cord blood banking industry is the most mature cord blood banking market in the world, having the:

First company to offer cord blood storage (1995)One of the first companies to offer cord tissue storage (2010)Largest total number of industry participants (both public and private)Greatest number of cord blood units (CBU) storedMost cord blood units (CBU) banked per capita

 

On the necessity of the report to the success of cord blood banks, Lance Breastgoff pointed out, “Other companies have already claimed this report and are implementing services based on it.  Can you afford to let them have that edge in an industry that’s grown 21-times more competitive in less than ten years?”

 

For a full table of contents and to access free product samples from the “Complete 2013-14 U.S. Cord Blood Banking Industry Report,” please visit: http://sevenseasresearch.com/index.php?route=product/product&product_id=56&search=complete

 

 

Call us now and claim this study at a DISCOUNTED PRICE:

 

Ph: 754-264-0777

Email: info@sevenseasresearch.com

www.sevenseasresearch.com

more...
No comment yet.
Scooped by Mark Stiffler - Seven Seas Research
Scoop.it!

Complete 2012-13 Induced Pluripotent Stem Cell Industry Report (June 2013)

Complete 2012-13 Induced Pluripotent Stem Cell Industry Report (June 2013) | Stem Cell Market Research | Scoop.it
Induced Pluripotent Stem Cell: Diseases such as Huntington’s Chorea, Parkinson’s Disease, and spinal cord injuries are examples of clinical applications.

 

Call us now and claim this study at a DISCOUNTED PRICE:

Ph: 754-264-0777

Email: info@sevenseasresearch.com

Mark Stiffler - Seven Seas Research's insight:

 

Complete 2012-13 Induced Pluripotent Stem Cell Industry Report (June 2013)

 

Dominate the iPSC Product Market by Making Smarter Decisions, Faster.


Groundbreaking experimentation in 2006 led to the introduction of induced pluripotent stem cells (iPSC). These are adult cells which are isolated and then transformed into embryonic-like stem cells through the manipulation of gene expression, as well as other methods. Since then, a large and thriving products market has grown into existence for the cell type. The number of iPSC research products sold worldwide has been grown at a rate of 14.7% for the past five years. In addition, 22.1% of all stem cell researchers now self-report as having used induced pluripotent stem cells within a research project.

 

Also, a distinctive feature of this report is an end-user survey of 293 researchers (181 U.S. / 112 International) that identify as having induced pluripotent stem cells as their research focus. Furthermore, the pharmaceutical sector has great interest in iPSC product development, due to the potential for use of iPSCs in drug target validation, toxicology testing, tissue engineering, cellular therapy, personalized medicine, and more. In summary, this is a must-read industry report for companies to optimally position themselves to sell iPSC products and technologies. Learn trends, metrics, and little known industry secrets to profit from this expanding market - or your competition will. 


KEY FINDINGS:

 

• Charts, Timelines, and Financials for the iPSC Product Market
• Trends for iPSC Grants, Scientific Publications, and Patents
• 5-Year Market Size Projections (2013-2017)
• Competitive Environment Analysis, including Market Share by      Competitor
• Preferred Species for iPSC Research
• iPSC Product Categories (Breakdown of Market Share by Each)
• Consumer Behavioral Patterns and Preferred Providers
• Crucial Trends and Unmet Market Needs
• “Tested Sentences” for Selling to iPSC Scientists
• Breakdown of the Marketing Methods Used by Industry Participants
• End-User Survey of iPSC Researchers (181 U.S. / 112 International)

 

For a full table of contents and to access free product samples from the “Complete 2012-13 Induced Pluripotent Stem Cell Industry Report (June 2013)”, please visit: http://sevenseasresearch.com/index.php?route=product/product&product_id=51&search=Induced

 

 

Call us now and claim this study at a DISCOUNTED PRICE:

 

Ph: 754-264-0777

Email: info@sevenseasresearch.com

www.sevenseasresearch.com

 

more...
No comment yet.
Scooped by Mark Stiffler - Seven Seas Research
Scoop.it!

Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)

Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version) | Stem Cell Market Research | Scoop.it
The cord blood banking industry is one of the fastest growing industries in the world. In 2005, there were only 23 active cord blood banks worldwide.

 

Call us now and claim this study at a DISCOUNTED PRICE:

Ph: 754-264-0777

Email: info@sevenseasresearch.com

Mark Stiffler - Seven Seas Research's insight:

 

Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)

 

As of 2013, the cord blood banking industry is one of the fastest growing industries in the world. In 2005, there were only 23 active cord blood banks worldwide; today there are 485. This represents a 21-fold increase (2,100%) in industry growth, in less than a ten-year period. This industry report reveals strategies for dominating the cord blood banking industry, including tactics for global expansion and methods for investing in the sector. It also considers the impact of historical events, the importance of key findings and trends on market conditions, and rapidly changing aspects of the industry. A distinctive feature of this report is a global survey of expectant parents who reveal their deepest fears, core expectations, and factors influencing buying decisions. This section is your guide to growing, expanding, and profiting, by listening to the needs of your clients – expectant parents. In summary, this industry report is designed to improve the decision-making of cord blood banks worldwide, as well as to advise investors entering into this market.

 

For a full table of contents and to access free product samples from the “Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)”, please visit: http://sevenseasresearch.com/index.php?route=product/product&product_id=52&search=Cord+Blood

 

 

Call us now and claim this study at a DISCOUNTED PRICE:

 

Ph: 754-264-0777

Email: info@sevenseasresearch.com

www.sevenseasresearch.com

more...
No comment yet.
Scooped by Mark Stiffler - Seven Seas Research
Scoop.it!

Mesenchymal Stem Cells, Advances & Applications (June 2013)

Mesenchymal Stem Cells, Advances & Applications (June 2013) | Stem Cell Market Research | Scoop.it
Mesenchymal stem cells (MSCs) can make several types of cells belonging to our skeletal tissues, such as cartilage, bone and fat.

 

Call us now and claim this study at a DISCOUNTED PRICE:

Ph: 754-264-0777

Email: info@sevenseasresearch.com

Mark Stiffler - Seven Seas Research's insight:

 

Mesenchymal Stem Cells, Advances & Applications (June 2013): 

 

Put simply, this report will help you understand and profit from the mesenchymal stem cell (MSC) market – the fastest growing area of stem cell research. Updated to reflect the most current trends and including five year market projections, this report focuses on the advances in MSC research. In 125 pages you’ll explore research priorities by market segment, highlight individual labs and end-users of MSC products, understand the competitive environment for such products and discover market-leading trend analysis. If you’re looking to supply stem cell products to this rapidly growing and well-funded market, then this is the report for you. And buy today to get our 60-day money-back guarantee. 

 

For a full table of contents and to access free product samples from the “Mesenchymal Stem Cells, Advances & Applications (June 2013)” please visit: http://sevenseasresearch.com/index.php?route=product/product&product_id=54&search=Stem+Cells

 

Call now and claim this study at a DISCOUNTED PRICE:

 

Ph: 754-264-0777

Email: info@sevenseasresearch.com

www.sevenseasresearch.com

 

more...
No comment yet.